Treatment | Control | Rh2(H2cit)4 | Magh-Rh2(H2cit)4 | Magh-citrate |
---|---|---|---|---|
Hematology parameters | ||||
WBC (/mm3) | 18445.50± 6020.68 | 24555.00 ± 9693.69 | 45774.00 ± 11995.51 | 59060.00 ± 25390.07 |
RBC (x109/mm3) | 8.69±0.27B | 10.82± 1.19 | 10.07 ± 1.03 | 10.17 ± 0.86 |
HGB (g/dL) | 13.60±0.42 | 14.75 ± 0.33 | 14.26 ± 0.14 | 13.36 ± 0.85 |
HCT (%) | 41.60±1.38 | 44.62 ± 0.96 | 44.40 ± 0.39 | 41.09 ± 2.51 |
Lymphocytes (%) | 28.75±6.65 | 38.50 ± 13.88 | 10.80± 3.35 | 18.71 ± 7.66 |
Rods (%) | 1.25±1.25 | 0.50 ± 0.50 | 0.00 ± 0.00 | 1.43 ± 0.65 |
Segmented (%) | 67.00±7.14 | 57.67 ± 13.40 | 84.00 ± 3.36 | 70.57 ± 7.40 |
Eosinophils (%) | 0.00±0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.14 ± 0.14 |
Basophils (%) | 0.25±0.25 | 0.17 ± 0.17 | 0.00 ± 0.00 | 0.14 ± 0.14 |
Monocytes (%) | 2.75±0.75 | 3.17 ± 1.01 | 5.20 ± 1.11 | 9.00 ± 4.94 |
Biochemical parameters | 25.20±6.22 | 25.50 ± 3.57 | 20.86 ± 2.15 | 21.33 ± 3.38 |
ALT (U/L) | 0.10±0.00 | 0.10 ± 0.00 | 0.10 ± 0.00 | 0.13 ± 0.02 |
Creatinine (mg/dL) | 125.60±18.59 | 143.67 ± 14.22 | 127.57 ± 12.10 | 112.33 ± 15.23 |
Serum Fe (mg/dL) |